Patent ID: 8119596
Filing Date: 2012-02-21
Classification: A61K,A61P

Abstract:
1. A method of treating cancer comprising administering to an individual an amount of a composition effective to treat cancer, said composition comprising: a) cartilage, chondroitin sulfate, hyaluronic acid, or collagen in an amount effective in damaged tissue to act as an anti-inflammatory and anti-neo-angiogenic agent; b) at least one polar surface active lipid selected from the group consisting of phosphatidic acid, phosphatidylethanolamine, lecithin, phosphatidylcholine, phosphatidylserine, phosphatidylinositol, 2-lysolccithin, plasmalogen, choline plasmalogen, phosphatidylglycerol, diphosphatidylglycerol, sphingomyelin, and any combination of 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 of said polar surface active lipids; c) a plurality of enantiomerically pure L-amino acids and glycine, wherein the plurality of enantiomerically pure L-amino acids are L-Leucine, L-Lysine, L-Proline, L-Arginine, L-Valine, L-Aspartic Acid, L-Isoleucine, L Threonine, L-Tyrosine, L-Phenylalanine, L-Serine, L-Histidine, L-Alanine, L-Cystine, L-Tryptophan, L-Methionine, L-Glutamine, L-Cysteine and L-Glutamic Acid; d) taurine or L-carnitine or both taurine and L-carnitine; e) a component selected from the group consisting of polyoxyethylene sorbitan monooleate, sorbitan monooleate, grape seed extract, grape extract, and combinations thereof; and f) vitamins, minerals or trace elements selected from the group consisting of Vitamin B 12, Vitamin E, selenium, zinc, and combinations thereof.